Singlet Oxygen-Induced Mitochondrial Reset in Cancer: A Novel Approach for Ovarian Cancer Therapy (2024)

Peer-Reviewed Study · da Veiga Moreira J, Schwartz L, Jolicoeur M · November 21, 2024

da Veiga Moreira J, 2024-11-21: Ovarian cancer cell study using methylene blue plus light to generate singlet oxygen, reporting partial reversal of the Warburg effect and reduced ATP synthesis and proliferation in the most sensitive line.

Metabolomic analysis indicated that MB-induced SO production partially reversed the Warburg effect, suggesting a shift from glycolysis to oxidative phosphorylation.

abstract

da Veiga Moreira J, 2024-11-21: Ovarian cancer cell study using methylene blue plus light to generate singlet oxygen, reporting partial reversal of the Warburg effect and reduced ATP synthesis and proliferation in the most sensitive line. Study type: in-vitro cancer cell lines (OV1369-R2, TOV1369) plus ARPE-19 controls. N: n/a. Country: Canada. Dose: 0, 0.1, 1 and 10 microM MB, 10 microM used as the working point (MB10); light activation used for singlet-oxygen generation (wavelength not stated in the abstract). Product: methylene blue from Laboratoire Chimie-plus, Saint-Paul-de-Varax, France. Funder: Fondation de Polytechnique Montreal (UBR-3760032). Declared conflicts: none. Bearing is PARTLY because the Warburg reversal is reported as partial and was accompanied by ATP-synthesis inhibition. Also filed as MTG-006 (claims C1, C2). Study type: lab.